Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIL
3826
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
| $4.23M | ﹤0.01% |
287,500
+150,900
| +110% | +$2.18M |
|
3827
Primoris Services
PRIM
$4.48B
| $4.23M | ﹤0.01% |
153,100
-52,868
| -26% | -$1.22M |
|
3828
PUT
Amplify Junior Silver Miners ETF
SILJ
$3.95B
| $4.22M | ﹤0.01% |
258,900
-237,900
| -48% | -$3.47M |
|
|
FIRY
3829
PUT
Firy Inc
FIRY
$156M
| $4.22M | ﹤0.01% |
10,555
+7,770
| +279% | +$2.31M |
|
3830
PUT
Pacific Biosciences
PACB
$357M
| $4.22M | ﹤0.01% |
162,700
+120,900
| +289% | +$2.05M |
|
3831
Impinj
PI
$5.28B
| $4.21M | ﹤0.01% |
100,628
+37,099
| +58% | +$1.29M |
|
|
EXK
3832
Endeavour Silver
EXK
$3.16B
| $4.21M | ﹤0.01% |
835,349
+494,659
| +145% | +$1.83M |
|
3833
CALL
Nektar Therapeutics
NKTR
$2.49B
| $4.21M | ﹤0.01% |
16,507
+1,360
| +9% | +$351K |
|
3834
WisdomTree US High Dividend Fund
DHS
$1.6B
| $4.21M | ﹤0.01% |
60,656
+36,426
| +150% | +$2.43M |
|
3835
Principal Active High Yield ETF
YLD
$584M
| $4.21M | ﹤0.01% |
211,904
+28,264
| +15% | +$547K |
|
3836
CALL
Main Street Capital
MAIN
$5.5B
| $4.2M | ﹤0.01% |
130,200
+18,300
| +16% | +$562K |
|
3837
PUT
Knight Transportation
KNX
$11.8B
| $4.2M | ﹤0.01% |
100,400
+29,400
| +41% | +$1.2M |
|
3838
CALL
Arthur J. Gallagher & Co
AJG
$64.4B
| $4.19M | ﹤0.01% |
33,900
+22,400
| +195% | +$2.55M |
|
3839
PUT
Boyd Gaming
BYD
$6.11B
| $4.19M | ﹤0.01% |
97,700
-57,800
| -37% | -$2.13M |
|
3840
PAR Technology
PAR
$788M
| $4.19M | ﹤0.01% |
66,779
+38,352
| +135% | +$1.88M |
|
3841
PUT
Alamos Gold
AGI
$14B
| $4.19M | ﹤0.01% |
478,700
+271,500
| +131% | +$2.41M |
|
3842
iShares US Basic Materials ETF
IYM
$1.02B
| $4.18M | ﹤0.01% |
36,875
+5,224
| +17% | +$556K |
|
3843
PUT
Dover
DOV
$27.9B
| $4.18M | ﹤0.01% |
33,100
-17,500
| -35% | -$2.08M |
|
3844
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $4.17M | ﹤0.01% |
67,930
+41,647
| +158% | +$2.35M |
|
3845
PUT
Voya Financial
VOYA
$9.2B
| $4.17M | ﹤0.01% |
70,900
-26,300
| -27% | -$1.43M |
|
3846
Vanguard ESG International Stock ETF
VSGX
$6.83B
| $4.17M | ﹤0.01% |
70,345
-47,001
| -40% | -$2.6M |
|
3847
Kodiak Sciences
KOD
$2.6B
| $4.17M | ﹤0.01% |
28,375
-12,115
| -30% | -$1.35M |
|
3848
UGI
UGI
$7.59B
| $4.17M | ﹤0.01% |
119,133
+63,239
| +113% | +$2.21M |
|
|
KWAC.U
3849
DELISTED
Kingswood Acquisition Corp. Units, each consisting of one share of Class A Common Stock and three-fo
KWAC.U
| $4.16M | ﹤0.01% |
+400,000
| New | +$4.08M |
|
3850
CALL
Crown Holdings
CCK
$12.9B
| $4.16M | ﹤0.01% |
41,500
-2,100
| -5% | -$193K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.